用于开窗腔内主动脉修复的简化裸导丝靶血管(SMART)技术
本研究介绍用于开窗腔内主动脉修复(FEVAR)的简化裸导丝靶血管(SMART)技术,并回顾性分析2018年5月至2020年12月57例肾旁或胸腹主动脉瘤患者的初步结果。技术成功率为96.4%(55/57),靶血管技术成功率为98.2%,90天内无死亡,中期靶血管通畅率可接受。
要点
- SMART技术避免在主支架释放时将引导鞘送入内脏动脉,使用12至16Fr对侧导引鞘。
- 57例患者中主要技术成功率为96.4%(55/57),靶血管技术成功率为98.2%。
- 90天内无死亡,主要不良事件包括急性肾损伤3例(5%)、呼吸衰竭需延长通气2例(4%)、心肌缺血1例(2%)。
核心结论
- SMART技术被证明是标准FEVAR的安全替代方案,技术结果优异,中期靶血管通畅率可接受,同时降低导引鞘所致下肢缺血、相关并发症和发病率的风险。
研究设计与样本
- 回顾性分析2018年5月至2020年12月连续57例接受FEVAR的肾旁或胸腹主动脉瘤患者,采用SMART技术。
主要发现
- 中位总手术时间为223(196-271)分钟,中位总透视时间为81(71-94)分钟。
- 主要技术成功率为96.4%(55/57),支架释放过程中未发生错位。
- 共169个开窗,包括左肾动脉54个、右肾动脉53个、肠系膜上动脉43个和腹腔干18个(每例患者3.0±0.9个血管),靶血管技术成功率为98.2%。
- 90天内无死亡(0%),主要不良事件包括急性肾损伤3例(5%)且无新发透析、呼吸衰竭需延长通气2例(4%)、心肌缺血1例(2%),无下肢缺血、卒中或脊髓缺血发生。
- 平均随访14±10个月后,发生1例主动脉相关死亡;主要和辅助主要靶血管通畅率分别为94.6%±1.8%和97.0%±1.3%。
临床怎么用
- SMART技术需要12至16Fr对侧导引鞘,取决于开窗数量,而标准3至4开窗FEVAR为18至22Fr。
- 开窗依次置管,借助可操纵鞘辅助,每个开窗中保留Rosen导丝,释放开窗支架时单一鞘停放在最终靶血管中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to present a new technique for fenestrated endovascular aortic aneurysm repair (FEVAR) and to review its preliminary results. The SiMplified bARe-wire Target vessel (SMART) technique for FEVAR aims to simplify the procedure by avoiding guiding sheaths into visceral arteries during the main graft deployment. MATERIALS AND METHODS: The SMART technique requires a 12 to 16Fr contralateral introducer, depending on number of fenestrations-compared with standard 18 to 22Fr for 3 to 4 FEVAR-to achieve target vessel catheterization and stenting during FEVAR by avoiding the use of parallel 6 to 7Fr guiding sheaths into each visceral vessel. Fenestrations are sequentially catheterized, assisted by a steerable sheath. A Rosen wire is maintained in each fenestration, with a single sheath parked in the final target vessel while releasing the fenestrated graft. Data on patients treated for pararenal or thoracoabdominal aortic aneurysms with FEVAR, adopting the SMART technique, were retrospectively reviewed. End points were technical success, intraprocedural variables, 90-day mortality, major adverse events (MAEs), and target vessel patency. RESULTS: From May 2018 to December 2020, 57 consecutive patients were treated for pararenal or thoracoabdominal aortic aneurysms. Median total procedure time and total fluoroscopy time were 223 (196-271) minutes and 81 (71-94) minutes, respectively. Primary technical success was 96.4% (55/57). No misalignment occurred from graft deployment. The total number of fenestrations was 169, including 54 left and 53 right renal arteries, 43 superior mesenteric arteries and 18 celiac trunks (3.0±0.9 vessels/patient), with target vessel technical success of 98.2%. During the first 90 days, there were no deaths (0%). The MAEs included acute kidney injury (AKI) in 3 patients (5%) with no new dialysis onset, respiratory failure requiring prolonged ventilation in 2 patients (4%), myocardial ischemia in 1 patient (2%), but no lower limb ischemia, stroke, or spinal cord ischemia (SCI) occurred. After a mean follow-up of 14±10 months, there was 1 aortic-related death. Primary and assisted primary target vessel patency was 94.6%±1.8 and 97.0%±1.3% respectively. CONCLUSIONS: The SMART technique proved to be a safe alternative to standard FEVARs, with excellent technical result and acceptable target vessel patency at mid-term, while reducing the risk for introducer-induced lower limb ischemia, related complications, and morbidity. CLINICAL IMPACT: This study evalautes the outcome of fenestrated endovascular aortic repair (FEVAR) procedures at Uppsala university hospital using a simplified bare-wire Target vessel (SMART) technique. The SMART technique requires a smaller contralateral introducer compared to standard 18-22Fr for 3-4 FEVAR to achieve target vessel catetherization and stenting. Fifty-seven consecutive patients were treated for pararenal or thoracoabdominal aortic aneurysms. The SMART technique proved to be a safe alternative to standard FEVARs with excellent technical result and acceptable target vessel patency at mid-term, while reducing the risk for introducer-induced lower limb ischemia, related complications, and morbidity.
引用
- Zuccon G, Wanhainen A, Lindström D, et al. A SiMplified bARe-Wire Target Vessel (SMART) Technique for Fenestrated Endovascular Aortic Repair. J Endovasc Ther. 2022. PMID: 36113080. doi:10.1177/15266028221121746
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。